Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement.

Keyphrases

• Hypertension 100%
• Coronary Artery Disease 100%
• Beta-blockers 100%
• Thiazide Diuretics 100%
• Scientific Statement 100%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 100%
• Angiotensin Receptor Blockers 100%
• Hypertension Management 66%
• ST-elevation Myocardial Infarction (STEMI) 66%
• Left Ventricular Dysfunction 66%
• Diltiazem 66%
• Verapamil 66%
• Stable Angina 66%
• Blood Pressure Goals 33%
• Antihypertensive Drugs 33%
• Black Men 33%
• Ischemic Heart Disease 33%
• Blood Pressure Lowering 33%
• Calcium Channel Blockers 33%
• Loop Diuretics 33%
• Blood Pressure Target 33%
• Aldosterone Antagonists 33%
• Dihydropyridine Calcium Channel Blockers 33%
• Hydralazine 33%
• Isosorbide Dinitrate 33%
• Severe Heart Failure 33%
• Adults with Hypertension 33%

Medicine and Dentistry

• Blood Pressure 100%
• Coronary Artery Disease 100%
• ACE Inhibitor 100%
• Angiotensin Receptor Antagonist 100%
• Beta Adrenergic Receptor Blocking Agent 100%
• Thiazide Diuretic Agent 100%
• Heart Left Ventricle Failure 66%
• Diltiazem 66%
• Calcium Channel Blocking Agent 66%
• Verapamil 66%
• Antihypertensive Agent 33%
• Congestive Heart Failure 33%
• Non ST Segment Elevation Myocardial Infarction 33%
• Ischemic Heart Disease 33%
• ST Segment Elevation Myocardial Infarction 33%
• Unstable Angina Pectoris 33%
• Stable Angina Pectoris 33%
• Loop Diuretic Agent 33%
• Aldosterone Antagonist 33%
• Isosorbide Dinitrate 33%
• Hydralazine 33%
• Dihydropyridine 33%
• Preference 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronary Artery Disease 100%
• Thiazide Diuretic Agent 100%
• Beta Adrenergic Receptor Blocking Agent 100%
• Dipeptidyl Carboxypeptidase Inhibitor 100%
• Angiotensin Receptor Antagonist 100%
• Heart Left Ventricle Failure 66%
• Diltiazem 66%
• Verapamil 66%
• Calcium Channel Blocker 66%
• Antihypertensive Agent 33%
• Congestive Heart Failure 33%
• ST Segment Elevation Myocardial Infarction 33%
• Ischemic Heart Disease 33%
• Stable Angina Pectoris 33%
• Unstable Angina Pectoris 33%
• Non ST Segment Elevation Myocardial Infarction 33%
• Aldosterone Antagonist 33%
• Isosorbide Dinitrate 33%
• Hydralazine 33%
• Loop Diuretic Agent 33%
• Dihydropyridine 33%
• Preference 33%